Hypotheses: The investigators hypothesize that patients who have the clinical characteristics of type 2 diabetes but have severe loss of endogenous insulin secretion will have markedly increased glycaemic variability (and therefore hypoglycaemia risk), and decreased response to non-insulin glucose lowering treatment in comparison to patients with similar clinical characteristics but preserved endogenous insulin.